‼️🚨🗓️ CONTAMCALENDAR 2026 🗓️🚨‼️ Excited to say the ContamCalendar is back for its fifth edition! We’ve created a fresh new design, folding out for an A3 monthly spread. It’s our best yet, we hope you’ll love it 🗓️🦠🧫🍄 Get yours here ➡️ www.contam.club ⬅️

It's confirmed. Abbott will acquire Exact Sciences $EXAS for $23B

Sofinnova's new fund includes a commitment from the UK goverment economic development bank lifesciencesweek.london/resource/bri...

I hate to be the one to tell you this, but, due to its position in the supply chain, NVIDIA earnings are a lagging indicator of any bursting of an investment bubble in AI.

In a new phase 3 trial, people randomly assigned to receive a flu shot made with modified mRNA were 34.5% less likely to be diagnosed with an influenza-like illness than people given a standard flu shot made with inactivated virus. We need to stop the anti-science attacks against mRNA vaccines!

Look if you had one ring with one Pd in it, and pull everything onto one thread in one moment. would you break it or just let it slip? Great work by @jamesormson.bsky.social and @tomasnicolas.bsky.social now in @angewandtechemie.bsky.social! #chemsky onlinelibrary.wiley.com/doi/10.1002/...

European #Spinouts Report just dropped dealroom.co/reports/euro...

“university spin-out sector was an “incredible UK success story and it has only happened in the last decade, starting with the Oxford, Cambridge and Imperial ‘triangle’ and it is spreading out beyond, to Edinburgh, Manchester, Sheffield, Leeds”. www.thetimes.com/article/ad65...

Netherlands agrees common template for university #spinouts thenextleap.is/news/dutch-s...

The Commission wants to open #HorizonEurope to more newcomers, from SMEs and start-ups to civil society and small public administrations. Simpler calls and lighter applications are meant to lower the barrier to entry. 📍 Read more:

Insight into recent goings on at the Ellison Institute of Technology www.ft.com/content/ae2c...

that's right, fraud is when you take money for something you don't do

Ooh this is nifty

As I told the CNN, without details and data it is not possible to assess the claims. More importantly, the scientific value of this media campaign, balanced against the possible stigmatization of individuals with these real conditions today, is highly questionable. edition.cnn.com/2025/11/13/s...

Good reason to get rid of cover letters in job applications

Unless you are planning to leave the county to avoid tax, why would you campaign against a tax on people leaving the country to avoid tax?

Whoah EBV not only causes multiple sclerosis, it also might be the root of SLE www.science.org/doi/10.1126/... An EBV vaccine to rid ourselves of these horrible autoimmune conditions (and many cancers)? #lupus #medsky #RheumSky @christosargyrop.bsky.social

CereCura Nanotherapeutics wants to leverage tech that powered COVID-19 vaccines to treat disorders like Alzheimer’s and Parkinson’s disease. The UBC spinout's $1.4 million, all-equity seed was led by WUTIF Capital, with support from eFund, UBC Venture Funds, and HexTwo Capital.

Interesting piece on Metsera from a UK #biotech perspective www.thetimes.com/us/business/... #spinout

Jeez, sounds like the scientific paper mills have found a new outlet

New #biotech #spinout from Oxford - Scripta is aiming to modulate transcription factors (drugging them directly is hard) www.eu-startups.com/2025/11/the-...

NZ is implementing an experiment in academic IP commercialisation thenextleap.is/news/new-zea... #spinout

New #biotech #spinout from Oxford - Scripta is aiming to modulate transcription factors (drugging them directly is hard) www.eu-startups.com/2025/11/the-...

The devil is in the details Atomically accurate de novo design of antibodies with RFdiffusion www.nature.com/articles/s41... success rates against each target range from 0% to 2% 😆 for SARS-CoV2 RBD target, 9000 designs screened, 5 SPR confirmed binders.

Good news in UK #biotech www.fiercebiotech.com/biotech/lill...

The most effective and commercially successful household robots are stationary white cubes that usually cost under £300. The most effective and commercially successful household robots that are mobile are disks with wheels underneath that usually cost under £700. Neither are £25k+ bipedal humanoids

UK government has publihsed its strategy for replacing and reducing aminal testing in research and for regulatory purposes www.gov.uk/government/n...

Found an interesting post on LinkedIn* on publishing vs patenting in the age of AI *the second time in a week, what's happening? www.linkedin.com/posts/simon-...

This image shows a mass of human stem cells, collectively known as an ‘organoid’. We stained the neural crest cells of this organoid to better understand diseases related to defects in their development, such as Hirschsprung's disease and Neuroblastoma. Image credit: @carmenmorenogon.bsky.social

Do you think this deal will work out for Pfizer? My feeling is that the earning lifetime of Metsera’s lead products will be short as better (e.g. oral, muscle preserving) anti obesity drugs are just around the corner www.ft.com/content/d9f5...

Scientific breakthroughs are rarely unique; someone else would’ve made them soon enough. But when prominent scientists cause harm, that harm isn’t inevitable; the world might simply have been better had the harm not been inflicted. liorpachter.wordpress.com/2018/05/18/j...

Happy 158th Birthday, Marie Skłodowska Curie! She was the first woman to receive a Nobel Prize and the first person to receive the honor twice. In 2017, #ScienceBooks toured the dynamics that established her as "the most iconic of all female scientists." https://scim.ag/47tkKYA

In today's episode of Biomolecules Doing Unexpected Things - Telomerase Reverse Transcriptase messes about in mitochondria

More strange shenanigans in #biotech "Biohub spokesperson said it was acquiring EvolutionaryScale’s team of about 50 people, but not buying the company itself. It’s unclear what will happen to any of its assets." endpoints.news/zuckerberg-b...

In today's episode of Biomolecules Doing Unexpected Things - Telomerase Reverse Transcriptase messes about in mitochondria

More strange shenanigans in #biotech "Biohub spokesperson said it was acquiring EvolutionaryScale’s team of about 50 people, but not buying the company itself. It’s unclear what will happen to any of its assets." endpoints.news/zuckerberg-b...

My favorite comment on the FT story

Beautiful discovery by the Huber and Kubicek labs and a wonderful example of using targeted protein degradation to probe novel non-catalytic functions.

Today I learned that Fokker-Planck is an important equation and not just what science students say when they learn who is responsible for the birth of quantum physics

Saturation genome editing and why it's important

How does immunotherapy work, and why do some patients respond while others don’t? Book our free talk by Samra Turajlic, head of the Cancer Dynamics Lab here at the Crick, Director of @cruk-mi.bsky.social and head of the UK-wide MANIFEST programme. www.eventbrite.co.uk/e/crick-cras...

"How to spin research into profits" #spinout moneyweek.com/investments/...

For a very long time the USA has been the obvious first choice of where to seek approval for new drugs. People are starting to question that.

Burry’s Palantir trade is roughly an order of magnitude bigger—and more interesting imo—than the Nvidia puts.

This is a bit weird. Did the backers have unrealistic expectations?https://www.statnews.com/2025/11/04/arena-bioworks-research-institute-shuts-down/

Da da da dum dee dum dee dum

Da da da dum dee dum dee dum

This was written in 2017. The current political moment was completely avoidable. ”the pain of looking back and seeing that there was a small window in which it was possible to act, and then discovering how suddenly and irrevocably that window can be slammed shut.” www.newyorker.com/books/page-t...

Terrifying!

Two really interesting LinkedIn posts (IKR!) on modelling biological systems. Read the quoted one first. www.linkedin.com/pulse/right-...